WO1999043833A1 - Plantes transgeniques resistantes aux maladies - Google Patents
Plantes transgeniques resistantes aux maladies Download PDFInfo
- Publication number
- WO1999043833A1 WO1999043833A1 PCT/IB1998/000232 IB9800232W WO9943833A1 WO 1999043833 A1 WO1999043833 A1 WO 1999043833A1 IB 9800232 W IB9800232 W IB 9800232W WO 9943833 A1 WO9943833 A1 WO 9943833A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- pyruvate decarboxylase
- plants
- sequence
- expression
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title description 52
- 201000010099 disease Diseases 0.000 title description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 142
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 claims abstract description 78
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 36
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 30
- 230000004665 defense response Effects 0.000 claims abstract description 18
- 235000012015 potatoes Nutrition 0.000 claims abstract description 17
- 230000004936 stimulating effect Effects 0.000 claims abstract description 4
- 230000003834 intracellular effect Effects 0.000 claims abstract 2
- 230000014509 gene expression Effects 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 28
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 20
- 230000033458 reproduction Effects 0.000 claims description 20
- 210000001519 tissue Anatomy 0.000 claims description 18
- 244000052769 pathogen Species 0.000 claims description 15
- 241000723762 Potato virus Y Species 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 12
- 244000061176 Nicotiana tabacum Species 0.000 claims description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 9
- 241000208292 Solanaceae Species 0.000 claims description 6
- 241000588902 Zymomonas mobilis Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 244000201986 Cassia tora Species 0.000 claims description 4
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 4
- 230000007123 defense Effects 0.000 claims description 4
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 3
- 239000000411 inducer Substances 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 claims 4
- 230000003362 replicative effect Effects 0.000 claims 2
- 230000001131 transforming effect Effects 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 229940076788 pyruvate Drugs 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 208000035240 Disease Resistance Diseases 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000003902 lesion Effects 0.000 description 72
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 68
- 229920003266 Leaf® Polymers 0.000 description 37
- 235000000346 sugar Nutrition 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000005755 formation reaction Methods 0.000 description 20
- 208000015181 infectious disease Diseases 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 17
- 229920002472 Starch Polymers 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 235000019698 starch Nutrition 0.000 description 14
- 239000008107 starch Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 230000001717 pathogenic effect Effects 0.000 description 11
- 239000005720 sucrose Substances 0.000 description 11
- 150000008163 sugars Chemical class 0.000 description 11
- 239000000284 extract Substances 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000030833 cell death Effects 0.000 description 7
- 230000003278 mimic effect Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 229920000018 Callose Polymers 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 206010002660 Anoxia Diseases 0.000 description 5
- 241000976983 Anoxia Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 230000007953 anoxia Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 241000588901 Zymomonas Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- 102000012286 Chitinases Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 235000019687 Lamb Nutrition 0.000 description 2
- 101150034686 PDC gene Proteins 0.000 description 2
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 108010078540 bacterio-opsin Proteins 0.000 description 2
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 2
- 230000010001 cellular homeostasis Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000001573 invertase Substances 0.000 description 2
- 235000011073 invertase Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000007110 pathogen host interaction Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 101150038105 pr gene Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000028070 sporulation Effects 0.000 description 2
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- XOSXWYQMOYSSKB-LDKJGXKFSA-L water blue Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC(C=C2)=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C(C=C2)=CC=C2S([O-])(=O)=O)=CC(S(O)(=O)=O)=C1N.[Na+].[Na+] XOSXWYQMOYSSKB-LDKJGXKFSA-L 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000724328 Alfalfa mosaic virus Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 206010056740 Genital discharge Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 101000879603 Nicotiana tabacum Acidic endochitinase Q Proteins 0.000 description 1
- -1 P7AR-1 Proteins 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 description 1
- 241000709992 Potato virus X Species 0.000 description 1
- 241000710007 Potexvirus Species 0.000 description 1
- 241000710078 Potyvirus Species 0.000 description 1
- 108010083204 Proton Pumps Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000008649 adaptation response Effects 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 108010060641 flavanone synthetase Proteins 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007446 host cell death Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007959 normoxia Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 208000016021 phenotype Diseases 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000014848 ubiquitin-dependent protein catabolic process Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Definitions
- the present invention relates to plants and methods for their production, said plants being disease resistant due to transformation with pyruvate decarboxylase (PDC) encoding nucleic acid sequences.
- PDC pyruvate decarboxylase
- Preferred plants are those of the solanaceae family, and within said family preferred plants are potatoes.
- the disease resistance comprises resistance to Phytoph tora infestans and resistance to the potato virus Y.
- the plants' defense response to incompatible pathogen interactions is often manifested as rapid localized host cell death termed the hypersensitive response (HR) .
- HR hypersensitive response
- HR is thought to contribute to the containment of the pathogen and is associated with most but not all incompatible host-pathogen interactions and disease resistance (Dangl et al., 1996; Hammond-Kosack and Jones, 1996) .
- a battery of defense reactions are initiated by the plant.
- Purified bacterial elicitors can induce HR cell death and disease resistance response when applied locally to a plant " (He et al . , 1993) indicating that HR is a preset genetic program that can be activated by external factors .
- the dominant Lesl and the recessive lethal leaf spot ( llsl ) mutations mimic stereotypic symp- toms of Helminthospori um maydi s and Helminthospori um car- bonum infections on susceptible maize, respectively (Neuffer and Calvert, 1975; Walbot et al . , 1983).
- the goal of the present invention was to provide a method for stimulating defense response in plants leading to disease resistance, as well as disease resistant plants.
- pyruvate decarboxylase for example such of bacterial origin, like the one described by Conway T. et al . (1987), stimulates the defense response of plants transformed with the respective gene.
- one subject of the present invention is a method for stimulating the defense response of plants and plant cells leading to disease resistance, by in- creasing the average pyruvate decarboxylase level.
- Another subject of the present invention is to provide a method for producing a plant or plant cell or reproduction material of said plant comprising a pyruvate decarboxylase encoding DNA sequence incorporated in the genome of said plant, plant cell or reproduction material in a non-natural environment allowing the expression of said pyruvate decarboxylase.
- transgenic as it is used herein does not only refer to plants or plant cells or reproduction material or pyruvate decarboxylase production comprising or induced by a heterologous gene, but also by a homologous gene in a non-natural environment. However, due to possible down-regulation rather than overexpression of the target gene in the case of homologous genes, heterologous genes are preferred.) It was found that the defense response was induced in the transgenic plants, even in the absence of visible lesions.
- transgenic plants even those with lit- tie or no visible lesion development showed markedly enhanced resistance against pathogen infection, as for example infection with bacteria such as Erwinia, Pseudo- monas; fungi such as Fusari um, Al ternaria, Phyti um, Phytophtora and in particular Phytoph tora infestans; viruses such as Potexvirus, e.g. Potato Virus X and Potyvirus, in particular Potato Virus Y; mycoplasmas; nematodes; insects. For example a 10 to 300 fold decrease in the number of Phytophtora infestans sporangia was found compared to the wild-type. Also an infection with viruses such as the potato virus Y (PVYO803) showed a resistance of transgenic plants.
- bacteria such as Erwinia, Pseudo- monas
- fungi such as Fusari um, Al ternaria, Phyti um, Phytophtora and in particular
- the pyruvate decarboxylase gene Due to the fact that the transgenic plants comprising the pyruvate decarboxylase gene have a more or less strong tendency to form lesions, it is preferred that the pyruvate decarboxylase gene is present in a form providing minimal pyruvate decarboxylase related lesions with maximum pathogen resistance under the desired or most likely environmental conditions.
- the transgenics usually produce higher (generally about 5 to 12-fold higher) levels of acetaldehyde and they usually export a higher (generally about 2 to 10-fold higher) level of sucrose from the leaves compared to the wild- type.
- Starch content on the contrary, can be drastically reduced in the high level PDC expressing plants such as potatoes.
- Analysis of physiological and molecular markers of hypersensitive cell death revealed that defense reactions similar to the HR were initiated in the potato transgenic plants. These included: deposition of callose in the leaf tissue, high level induction of pathogenesis- related (PR) protein encoding transcripts, and heightened resistance to pathogens such as fungus or viruses, e.g. P. infestans and potato virus Y.
- PR pathogenesis-related
- the present invention is not limited to a specific pyruvate decarboxylase, e.g. of Zymomonas mobi - lis nor to specific plants, although potatoes - because of their great relevance as nutrient - are preferred plants.
- any pyruvate decarboxylase encoding DNA sequence with the ability to enhance the naturally present pyruvate decar- boxylase level (without killing the plant) is suitable.
- Suitable DNA sequences are e.g. all sequences encoding a pyruvate decarboxylase or a fragment or mutation thereof 6
- DNA sequences can be naturally occurring genomic sequences or cDNA sequences, sequences that are identical with such sequences but for the degeneracy of the genetic code as well as sequences encoding fragments and mutations provided that they stimulate defense response.
- Said encoding sequences can either be introduced into a suitable environment of the genome of the plant to be transformed ena- bling the expression of pyruvate decarboxylase or they can be introduced into the genome of the plant together with their natural or adapted regulatory sequences.
- the nucleotide sequence can be introduced into the plant, plant cells, parts of plants such as tissue or reproduc- tion material by any transformation method leading to incorporation of the nucleic acid sequence into the genome of the plant, plant cells, plant tissue or reproduction material.
- Reproduction materials include stems, tubers, leafs, and cells, with tubers being preferred for pota- toes, but also calli.
- a first interpretation of the results obtained might be that the response is triggered by an interaction of acetaldehyde with a component of the cell death machinery.
- the physical and chemical properties of acetaldehyde will determine its interaction with endogenous molecules.
- potatoes incubated under anoxia to enhance pyruvate decarboxylase activity, and exposed back to air produced high acetaldehyde levels, but no lesions could be observed.
- an enhanced pyruvate decarboxylase activity might lead to lesion formation and pathogen resistance.
- transgenic plants were measured, it was found that acetaldehyde accumulated to higher levels in the transgen- ics grown at 18 °C compared to the wild-type, and that L-8 produced as much acetaldehyde in the 25°C as any other of the transgenic potatoes at the 18°C growth condition.
- the transgenic potatoes showed lesions at 18 °C, whereas L-8 at 25°C was virtually unaffected.
- non-transformed potatoes incubated under anoxia and exposed back to air it was found that they produced high levels of acetaldehyde equivalent to L-8 under normoxia at 18 °C, but no lesions were observed.
- another or other factors could also be relevant for the lesion formation and the defense response.
- an increased amount of pyruvate decarboxylase in the cell in comparison with the wild type over a sufficient long time to activate defense response is likely to be the main factor.
- any other method to increase said amount is also within the scope of the present invention, i.e. the application of pyruvate 'decarboxylase in any kind of carrier enabling the introduction of PDC into plant cells.
- the lesion formation is largely reduced to ensure a good harvest with at the same time enhanced pathogen resistance.
- This can e.g. be obtained by selection of the minimal lesion forming plants showing resistance or by variation of the promoter, e.g. by selecting a promoter that needs specific activation by a specific inducer.
- Figure 1 shows the Zymomonas PDC expression and in vi tro enzymatic activity
- Figure 1A representing the Zymomonas PDC protein expression in potato leaves, whereby twenty micro- grams of total soluble protein were loaded per lane and probed with anti- Zymomonas PDC antibody
- Figure IB representing the PDC enzymatic activity, whereby the PDC activity was measured in the leaf 9
- Figure 2 shows the acetaldehyde concentration in potato leaf tissue
- Figure 2A showing chromatograms of control experiments, with the peaks representing: blk, water blank; con, control in which the wild-type leaf extract was incubated at 37 °C for 1 h; wt, wild-type leaf untreated; anx, wild-type leaf incubated under anoxia for 2 h and 10 in air; std, acetaldehyde standard (l ⁇ M), and
- Figure 2B representing the acetaldehyde from plant leaves grown at 18 ⁇ 3°C
- Figure 2C representing the acetaldehyde from plant leaves grown at 25+2 °C, whereby the acetaldehyde was measured as a fluorescent adduct with 1, 3-cyclohex- anedione in a perchloric acid extract of 4 week old leaves by HPLC, and whereby the values represent the mean + SE of 6 independent measurements.
- Figure 3 shows the accumulation of PR gene transcripts in transgenic potato leaves, whereby total RNA (10 ⁇ g) from healthy (-lesion) or lesioned (+lesion) leaves of line 25 was loaded per lane and probed with specific cDNA probes indicated on the left side.
- Figure 4 shows soluble sugars and starch in potato leaves, whereby the values represent the mean ⁇ SE of 5 measurements of individual plants, and whereby
- Figure 4A represents the concentration of starch and soluble sugars in the leaf tissue from plants grown at 18 ⁇ 3°C
- Figure 4B represents the concentration of soluble sugars in the petiole exudates of plants grown at 18 ⁇ 3°C
- Figure 4C represents the concentration of soluble sugars in the petiole exudates of plants grown at 25+2 °C.
- Figure 5 shows resistance tests to the fungus
- Phytophtora infestans particularly the sporulation efficiency 6 days post-infection, whereby the values represent the mean ⁇ SE of 3 leaves of 8 individual plants for each line.
- Figure 6 shows resistance tests to the PVY, particularly the virus titer measured by ELISA in three different wt and transgenic (L-17) plants.
- the PDC gene from the obligate anaerobe Zymomonas mobilis was in- serted between the alfalfa mosaic virus (7 ⁇ MV) transla- tional enhancer and the nos terminator under the control of the 35S promoter (Odell J.T. et al . , (1985)) as de ⁇ scribed in Bucher et al . , (1994).
- Transgene expression was variable and 4 lines accumulating the PDC protein to different levels (Figure 1A) were maintained in tissue culture by clonal propagation.
- the in vi tro PDC enzymatic activity correlated with the level of protein accumulation, and showed more than a 6-fold increase in the case of highest expression in line 8 (L-8) as compared to the wild-type (wt) ( Figure IB) .
- the transgenic plants displayed a lesion mimic phenotype, the severity of which correlated with the expression level of the ZymPOC protein, the highest expressors showing the most extensive lesions. Lesions began to develop about 4 weeks after planting in soil. In most cases, the lesion started at the tip of source leaves near the midrib as small brownish spots, and spread in all directions, primarily along the midrib and the veins. Within 3 to 5 days of the start of lesion formation, the lesion encompassed most of the leaf area leading to a dry, grey to brownish, and shrunken appearance. Finally, the whole leaf collapsed and abscised. The lesion continued to the next fully expanded source leaf, and proceeded to the one above even before the complete collapse of the one below it.
- the timing and progression of the lesion showed dependence on the level of the transgene expression.
- the lines that expressed the PDC protein at highest levels were the first to show the lesion appearance.
- the difference in symptom appearance between the highest expressor (L-8) and the least expressors (L-21 and L-17) was at least 6-10 days.
- the progression of the lesion was also dependent on the PDC protein levels.
- L-8 and L-25 the lesion spread was fast and uncontrolled, leading to the death of the entire plant within 2-3 weeks after the onset of lesion formation.
- L-17 and L-21 the lesions were localized, spread slowly to consume the entire leaf, but remained restricted to only a few source leaves, and never reached the top of the plant.
- the transgenic plants were not reduced in height before lesion formation, and L-17 and L-21 grew to 12
- Example 3 Acetaldehyde level in leaf tissue of transgenic potatoes
- PDC is known to catalyze the first step in ethanolic fermentation, a decarboxylation of pyruvate yielding acetaldehyde and C0 2 .
- ethanolic fermentation occurs only during oxygen limitation and some other stresses.
- An attempt for constitutive high level expression of bacterial PDC in tobacco leaves did neither lead to measurable acetaldehyde production nor to visible lesion formation in the presence of oxygen as de- 13
- Healthy leaf discs (2 per plant) were snap frozen in liquid nitrogen from leaf number 3 and 4 as counted from the top of a 4 week old potato.
- the leaves were extracted with 6% perchloric acid at 4°C and incubated on ice for 2 h. After incubation, the samples were spun at maximum microfuge speed for 10 min at 4°C.
- the supernatant was neutralized to pH 6.0-6.5 with 5M K 2 C0 3 on ice.
- the neutralized extract was spun again for 10 min as above, and the supernatant was transferred to a precooled Eppendorf and kept on ice until derivatization.
- Acetaldehyde in this extract was measured as a fluorescent adduct formed by a reaction with 1, 3-cyclohexanedione (CHD) essentially according to Helander et al . (1993).
- the reaction mixture contained 150 ⁇ l ammonium acetate (20%,w/v, in water), 150 ⁇ l thiourea (6%, w/v, in water), 50 ⁇ l CHD 1.25%, w/v, in water), and 150 ⁇ l extract added to a 2 ml glass bottle in this order. Each bottle was immediately sealed after adding the extract, and all samples were incubated at 60°C in a gently shaking water both for 1 h. The samples were cooled on ice and 20 ⁇ l aliquots were analyzed by high- performance liquid chromatography (HPLC) .
- HPLC high- performance liquid chromatography
- Rheodyne RH 7010 injector with a 100 ⁇ l sample loop (Beckmann, Nyon, Switzerland)
- Nucleosil 100-5 C18 reversed-phase analytical " column 40 x 250 mm i.d., 5 ⁇ m particle size; Macherey-Nagel, Oensingen, Switzerland
- the column was eluted isocratically at a flow rate of 1.0 ml/min at ambient temperature with a mobile phase consisting of methanol-water (40: 60, v/v) .
- a Kon- tron Model SFM-25 fluorescent detector (Kontron, Zurich, Switzerland) was used with excitation and emission wave- lengths of 366 and 440 nm, respectively.
- This method allowed the determination of low levels of acetaldehyde in actively respiring normoxic po- tato leaves (see Figure 2) .
- Figure 2A shows chromatograms of control experiments used to authenticate the assay conditions.
- a small background peak appeared which has the same retention time as the acetaldehyde adduct.
- a similar background peak was observed by Helander et al . (1993) .
- wild-type potato leaves were incubated under anoxia, in which more than a 10-fold increase in acetaldehyde peak area was observed compared to the untreated wild-type ( Figure 2A) .
- Figures 2B and C shows chromatograms of control experiments used to authenticate the assay conditions.
- L-21 at 18°C and L-8 at 25°C have comparable acetaldehyde levels, yet L-21 developed severe symptoms at 18°C, whereas L-8 at 25°C was virtually unaf- fected. This clearly indicates that in addition to acetaldehyde concentration other physiological and environmental factors must contribute to lesion formation.
- Example 4 Correlation between lesion formation and induction of the plant defense response
- Callose deposition represents one of the earliest plant defense responses (Bradley et al., 1992), al- though it is not an exclusive marker of HR.
- Callose deposition was detected as follows: Leaf discs for callose examination were bleached in a series of 50, 75 and 96% ethanol overnight. The cleared leaves were rinsed in water and stained for 1 h at room temperature in a humid chamber in a 0.05% (w/v) solution of aniline blue in 0.15 M K 2 HP0 4 . Stained leaves were examined under UV-light using excitation filter, 365 nm; dichromic mirror, 396 nm; and barrier filter, 420 nm. After treatment with aniline blue fluores- cence could be observed in transgenic leaves. 16
- Leaf discs (2 per plant) were collected in liquid nitrogen from fully expanded source leaves after 8h of the light period. Most of the L-8 and L-25 plants growing at the 18 °C showed lesions at the time of sam- pling (4-5 weeks after planting to soil), but samples were collected from healthy looking leaves. Leaves were homogenised in an Eppendorf tube with 80% ethanol (v/v) and extracted for 90 min at 70 °C. Samples were spun at 13 000 rpm for 10 min, and the supernatant was stored at - 20°C for soluble sugars (sucrose, glucose, and fructose) determination. The pellet was washed with 1 ml of 17
- sucrose translocation is a component of the developmentally regulated cell death initiation and exe- cution process.
- Example 6 Phytophtora infestans resistance of transgenic potatoes
- the response of the PDC transgenics to a virulent fungal inoculation was examined to determine whether the transgenics exhibit disease resistance.
- Transgenic and wild-type potato leaves were infected with the fungal pathogen Phytoph tora infestans , causative agent of late blight disease, to which the wild-type Desiree variety is susceptible. Both the trans- genie and wild-type leaves were completely healthy at the time of infection.
- An inoculum of Phytophtora infestans strain 94-18 was prepared by adding 15 ml of ice cold 0.5% glucose to a 3 weeks old culture on rye A medium (Ribeiro, 1978) . After 3 h incubation at 4°C to allow for the release of the zoospores, spores were counted and the concentration was adjusted to 25,000 per ml. Eight plants per line were grown in the greenhouse for 3 weeks at 24 +_ 2°C and transferred to 17°C for the infection test. On each plant, 3 leaves were infected with 4 droplets of 5 ⁇ l of spore suspension per leaf. Mock inoculations were 19
- Example 7 Resistance test of wild type and transgenic PDC potato plants (line 17) to infection by potato virus Y (PVY O803) .
- Wt plants showed symptoms of viral infection in the infected leaf but also showed PVY symptoms in the upper leaves of the plant.
- the transgenic plants showed symptoms in the inoculated leaf, but no le- sions developed in the rest of the plant.
- the inoculated leaf was found to contain viruses in both the wt and the transgenic plants 13 dpi. In the wt plants, the titer was high in the upper leaf 17 and 20 dpi. However the virus could not be detected in the upper leaves in the transgenic plants (Fig. 6) .
- transgenic plants showed a resistance to potato virus Y, both at the macroscopic level, with absence of any visible lesions, and at the ELISA analysis level, where the virus can not be detected in the upper leaf analyzed. While there are shown and described presently preferred embodiments of the invention, it is to be distinctly understood that the invention is not limited 21
- Pseudomonas syringae pv. syringae harpins Pss A protein that is secreted via the Hrp pathway and elicits the hypersensitive response in plants. CeJJ 73, 1255-1266.
- Salicylic acid-independent induction of pathogenesis-related protein transcripts by sugars is dependent on leaf developmental age.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU60031/98A AU6003198A (en) | 1998-02-26 | 1998-02-26 | Disease resistant transgenic plants |
PCT/IB1998/000232 WO1999043833A1 (fr) | 1998-02-26 | 1998-02-26 | Plantes transgeniques resistantes aux maladies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1998/000232 WO1999043833A1 (fr) | 1998-02-26 | 1998-02-26 | Plantes transgeniques resistantes aux maladies |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999043833A1 true WO1999043833A1 (fr) | 1999-09-02 |
Family
ID=11004689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1998/000232 WO1999043833A1 (fr) | 1998-02-26 | 1998-02-26 | Plantes transgeniques resistantes aux maladies |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6003198A (fr) |
WO (1) | WO1999043833A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003362A3 (fr) * | 2003-03-10 | 2005-04-21 | Athenix Corp | Methodes destinees a conferer une resistance aux herbicides |
US7807881B2 (en) | 2003-03-10 | 2010-10-05 | Athenix Corp. | Methods to confer herbicide resistance |
CN118562777A (zh) * | 2024-08-05 | 2024-08-30 | 中国热带农业科学院三亚研究院 | 一种具有抗病功能的ScPDC1蛋白及其编码基因和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002193A1 (fr) * | 1988-08-31 | 1990-03-08 | University Of Florida | Production d'ethanol par des souches d'escherichia coli mises au point genetiquement |
WO1997027295A1 (fr) * | 1996-01-23 | 1997-07-31 | Horticulture Research International | Genes associes au murissement des fruits |
-
1998
- 1998-02-26 WO PCT/IB1998/000232 patent/WO1999043833A1/fr active Application Filing
- 1998-02-26 AU AU60031/98A patent/AU6003198A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002193A1 (fr) * | 1988-08-31 | 1990-03-08 | University Of Florida | Production d'ethanol par des souches d'escherichia coli mises au point genetiquement |
WO1997027295A1 (fr) * | 1996-01-23 | 1997-07-31 | Horticulture Research International | Genes associes au murissement des fruits |
Non-Patent Citations (2)
Title |
---|
BUCHER M ET AL: "Ethanolic fermentation in transgenic tobacco expressing *Zymomonas* *mobilis* *pyruvate* *decarboxylase*.", EMBO J, JUN 15 1994, 13 (12) P2755-63, ENGLAND, XP002071433 * |
CONWAY, T. ET AL.: "Promoter and nucleotide sequence of the Zymomonas mobilis pyruvate decarboxylase", J. OF BACTERIOLOGY, vol. 169, 1987, pages 949 - 954, XP002071434 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003362A3 (fr) * | 2003-03-10 | 2005-04-21 | Athenix Corp | Methodes destinees a conferer une resistance aux herbicides |
US7807881B2 (en) | 2003-03-10 | 2010-10-05 | Athenix Corp. | Methods to confer herbicide resistance |
CN118562777A (zh) * | 2024-08-05 | 2024-08-30 | 中国热带农业科学院三亚研究院 | 一种具有抗病功能的ScPDC1蛋白及其编码基因和应用 |
CN118562777B (zh) * | 2024-08-05 | 2024-11-01 | 中国热带农业科学院三亚研究院 | 一种具有抗病功能的ScPDC1蛋白及其编码基因和应用 |
Also Published As
Publication number | Publication date |
---|---|
AU6003198A (en) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tadege et al. | Activation of plant defense responses and sugar efflux by expression of pyruvate decarboxylase in potato leaves | |
Herbers et al. | Systemic acquired resistance mediated by the ectopic expression of invertase: possible hexose sensing in the secretory pathway. | |
Hunt et al. | Systemic acquired resistance signal transduction | |
Li et al. | Overexpression of polyphenol oxidase in transgenic tomato plants results in enhanced bacterial disease resistance | |
Xia et al. | An extracellular aspartic protease functions in Arabidopsis disease resistance signaling | |
Dewdney et al. | Three unique mutants of Arabidopsis identify eds loci required for limiting growth of a biotrophic fungal pathogen | |
Johnson et al. | Wound-inducible potato inhibitor II genes: enhancement of expression by sucrose | |
Wu et al. | Disease resistance conferred by expression of a gene encoding H2O2-generating glucose oxidase in transgenic potato plants. | |
Beffa et al. | Cholera toxin elevates pathogen resistance and induces pathogenesis‐related gene expression in tobacco. | |
LeBrasseur et al. | Local and systemic wound‐induction of RNase and nuclease activities in Arabidopsis: RNS1 as a marker for a JA‐independent systemic signaling pathway | |
Karban et al. | Induced resistance against pathogens and herbivores: an overview | |
Helliwell et al. | Ethylene biosynthesis and signaling is required for rice immune response and basal resistance against Magnaporthe oryzae infection | |
Bienert et al. | A pleiotropic drug resistance transporter in Nicotiana tabacum is involved in defense against the herbivore Manduca sexta | |
Gandía et al. | Transcriptional response of Citrus aurantifolia to infection by Citrus tristeza virus | |
Sun et al. | A novel Medicago truncatula calmodulin‐like protein (MtCML42) regulates cold tolerance and flowering time | |
US8163979B2 (en) | Antifungal plant proteins and methods of their use | |
PL178652B1 (pl) | Zrekombinowana cząsteczka dwuniciowego DNA, sposób wytwarzania genetycznie stransformowanych, odpornych na choroby roślin, oraz genetycznie stransformowana komórka roślinna ziemniaka lub pszenicy | |
Manoharan et al. | Expression of 3-OH trichothecene acetyltransferase in barley (Hordeum vulgare L.) and effects on deoxynivalenol | |
O'mahony et al. | The involvement of ubiquitin in vegetative desiccation tolerance | |
Simmons et al. | The maize lethal leaf spot 1 mutant has elevated resistance to fungal infection at the leaf epidermis | |
CA2298882A1 (fr) | Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures | |
WO1999043833A1 (fr) | Plantes transgeniques resistantes aux maladies | |
EP1018553A1 (fr) | Plantes transgéniques avec les gènes divergents SCaM4 et SCaM5 pour obtenir une résistance aux maladies multiples | |
Bolingue et al. | The MtSNF4b subunit of the sucrose non‐fermenting‐related kinase complex connects after‐ripening and constitutive defense responses in seeds of Medicago truncatula | |
WO2014028426A1 (fr) | Compositions et procédés d'amélioration de la résistance des plantes contre les parasites |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |